Global Vasomotor Symptoms Of Menopause Treatment Market Size, Status And Forecast 2021-2027

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vasomotor Symptoms of Menopause Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Estetrol
1.2.3 Fezolinetant
1.2.4 FP-101
1.2.5 HBN-2
1.2.6 Others
1.3 Market by Application
1.3.1 Global Vasomotor Symptoms of Menopause Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Homecare
1.3.4 Clinic
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Vasomotor Symptoms of Menopause Treatment Market Perspective (2016-2027)
2.2 Vasomotor Symptoms of Menopause Treatment Growth Trends by Regions
2.2.1 Vasomotor Symptoms of Menopause Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Vasomotor Symptoms of Menopause Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Vasomotor Symptoms of Menopause Treatment Industry Dynamic
2.3.1 Vasomotor Symptoms of Menopause Treatment Market Trends
2.3.2 Vasomotor Symptoms of Menopause Treatment Market Drivers
2.3.3 Vasomotor Symptoms of Menopause Treatment Market Challenges
2.3.4 Vasomotor Symptoms of Menopause Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Vasomotor Symptoms of Menopause Treatment Players by Revenue
3.1.1 Global Top Vasomotor Symptoms of Menopause Treatment Players by Revenue (2016-2021)
3.1.2 Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Vasomotor Symptoms of Menopause Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Vasomotor Symptoms of Menopause Treatment Revenue
3.4 Global Vasomotor Symptoms of Menopause Treatment Market Concentration Ratio
3.4.1 Global Vasomotor Symptoms of Menopause Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vasomotor Symptoms of Menopause Treatment Revenue in 2020
3.5 Vasomotor Symptoms of Menopause Treatment Key Players Head office and Area Served
3.6 Key Players Vasomotor Symptoms of Menopause Treatment Product Solution and Service
3.7 Date of Enter into Vasomotor Symptoms of Menopause Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Vasomotor Symptoms of Menopause Treatment Breakdown Data by Type
4.1 Global Vasomotor Symptoms of Menopause Treatment Historic Market Size by Type (2016-2021)
4.2 Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Type (2022-2027)

5 Vasomotor Symptoms of Menopause Treatment Breakdown Data by Application
5.1 Global Vasomotor Symptoms of Menopause Treatment Historic Market Size by Application (2016-2021)
5.2 Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Vasomotor Symptoms of Menopause Treatment Market Size (2016-2027)
6.2 North America Vasomotor Symptoms of Menopause Treatment Market Size by Type
6.2.1 North America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021)
6.2.2 North America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027)
6.2.3 North America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2027)
6.3 North America Vasomotor Symptoms of Menopause Treatment Market Size by Application
6.3.1 North America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021)
6.3.2 North America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027)
6.3.3 North America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2027)
6.4 North America Vasomotor Symptoms of Menopause Treatment Market Size by Country
6.4.1 North America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2016-2021)
6.4.2 North America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Vasomotor Symptoms of Menopause Treatment Market Size (2016-2027)
7.2 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Type
7.2.1 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021)
7.2.2 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027)
7.2.3 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2027)
7.3 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Application
7.3.1 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021)
7.3.2 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027)
7.3.3 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2027)
7.4 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country
7.4.1 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country (2016-2021)
7.4.2 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size (2016-2027)
8.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Type
8.2.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Application
8.3.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Region
8.4.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Vasomotor Symptoms of Menopause Treatment Market Size (2016-2027)
9.2 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Type
9.2.1 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2027)
9.3 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Application
9.3.1 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2027)
9.4 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country
9.4.1 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size (2016-2027)
10.2 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Type
10.2.1 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Application
10.3.1 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country
10.4.1 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Details
11.1.2 Amgen Inc. Business Overview
11.1.3 Amgen Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.1.4 Amgen Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.1.5 Amgen Inc. Recent Development
11.2 EndoCeutics, Inc.
11.2.1 EndoCeutics, Inc. Company Details
11.2.2 EndoCeutics, Inc. Business Overview
11.2.3 EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.2.4 EndoCeutics, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.2.5 EndoCeutics, Inc. Recent Development
11.3 Euroscreen S.A.
11.3.1 Euroscreen S.A. Company Details
11.3.2 Euroscreen S.A. Business Overview
11.3.3 Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Introduction
11.3.4 Euroscreen S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.3.5 Euroscreen S.A. Recent Development
11.4 MenoGeniX, Inc.
11.4.1 MenoGeniX, Inc. Company Details
11.4.2 MenoGeniX, Inc. Business Overview
11.4.3 MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.4.4 MenoGeniX, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.4.5 MenoGeniX, Inc. Recent Development
11.5 Mithra Pharmaceuticals S.A.
11.5.1 Mithra Pharmaceuticals S.A. Company Details
11.5.2 Mithra Pharmaceuticals S.A. Business Overview
11.5.3 Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Introduction
11.5.4 Mithra Pharmaceuticals S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.5.5 Mithra Pharmaceuticals S.A. Recent Development
11.6 Pherin Pharmaceuticals, Inc.
11.6.1 Pherin Pharmaceuticals, Inc. Company Details
11.6.2 Pherin Pharmaceuticals, Inc. Business Overview
11.6.3 Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.6.4 Pherin Pharmaceuticals, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.6.5 Pherin Pharmaceuticals, Inc. Recent Development
11.7 Pivot Pharmaceuticals Inc
11.7.1 Pivot Pharmaceuticals Inc Company Details
11.7.2 Pivot Pharmaceuticals Inc Business Overview
11.7.3 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Introduction
11.7.4 Pivot Pharmaceuticals Inc Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.7.5 Pivot Pharmaceuticals Inc Recent Development
11.8 Radius Health, Inc.
11.8.1 Radius Health, Inc. Company Details
11.8.2 Radius Health, Inc. Business Overview
11.8.3 Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.8.4 Radius Health, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.8.5 Radius Health, Inc. Recent Development
11.9 TherapeuticsMD, Inc.
11.9.1 TherapeuticsMD, Inc. Company Details
11.9.2 TherapeuticsMD, Inc. Business Overview
11.9.3 TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.9.4 TherapeuticsMD, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.9.5 TherapeuticsMD, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Vasomotor Symptoms of Menopause Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Estetrol
Table 3. Key Players of Fezolinetant
Table 4. Key Players of FP-101
Table 5. Key Players of HBN-2
Table 6. Key Players of Others
Table 7. Global Vasomotor Symptoms of Menopause Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Vasomotor Symptoms of Menopause Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Vasomotor Symptoms of Menopause Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Vasomotor Symptoms of Menopause Treatment Market Share by Regions (2016-2021)
Table 11. Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Vasomotor Symptoms of Menopause Treatment Market Share by Regions (2022-2027)
Table 13. Vasomotor Symptoms of Menopause Treatment Market Trends
Table 14. Vasomotor Symptoms of Menopause Treatment Market Drivers
Table 15. Vasomotor Symptoms of Menopause Treatment Market Challenges
Table 16. Vasomotor Symptoms of Menopause Treatment Market Restraints
Table 17. Global Vasomotor Symptoms of Menopause Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Vasomotor Symptoms of Menopause Treatment Market Share by Players (2016-2021)
Table 19. Global Top Vasomotor Symptoms of Menopause Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vasomotor Symptoms of Menopause Treatment as of 2020)
Table 20. Ranking of Global Top Vasomotor Symptoms of Menopause Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Vasomotor Symptoms of Menopause Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Vasomotor Symptoms of Menopause Treatment Product Solution and Service
Table 24. Date of Enter into Vasomotor Symptoms of Menopause Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Vasomotor Symptoms of Menopause Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Amgen Inc. Company Details
Table 65. Amgen Inc. Business Overview
Table 66. Amgen Inc. Vasomotor Symptoms of Menopause Treatment Product
Table 67. Amgen Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 68. Amgen Inc. Recent Development
Table 69. EndoCeutics, Inc. Company Details
Table 70. EndoCeutics, Inc. Business Overview
Table 71. EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Product
Table 72. EndoCeutics, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 73. EndoCeutics, Inc. Recent Development
Table 74. Euroscreen S.A. Company Details
Table 75. Euroscreen S.A. Business Overview
Table 76. Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Product
Table 77. Euroscreen S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 78. Euroscreen S.A. Recent Development
Table 79. MenoGeniX, Inc. Company Details
Table 80. MenoGeniX, Inc. Business Overview
Table 81. MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Product
Table 82. MenoGeniX, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 83. MenoGeniX, Inc. Recent Development
Table 84. Mithra Pharmaceuticals S.A. Company Details
Table 85. Mithra Pharmaceuticals S.A. Business Overview
Table 86. Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Product
Table 87. Mithra Pharmaceuticals S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 88. Mithra Pharmaceuticals S.A. Recent Development
Table 89. Pherin Pharmaceuticals, Inc. Company Details
Table 90. Pherin Pharmaceuticals, Inc. Business Overview
Table 91. Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Product
Table 92. Pherin Pharmaceuticals, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 93. Pherin Pharmaceuticals, Inc. Recent Development
Table 94. Pivot Pharmaceuticals Inc Company Details
Table 95. Pivot Pharmaceuticals Inc Business Overview
Table 96. Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Product
Table 97. Pivot Pharmaceuticals Inc Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 98. Pivot Pharmaceuticals Inc Recent Development
Table 99. Radius Health, Inc. Company Details
Table 100. Radius Health, Inc. Business Overview
Table 101. Radius Health, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 102. Radius Health, Inc. Recent Development
Table 103. TherapeuticsMD, Inc. Company Details
Table 104. TherapeuticsMD, Inc. Business Overview
Table 105. TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Product
Table 106. TherapeuticsMD, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 107. TherapeuticsMD, Inc. Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vasomotor Symptoms of Menopause Treatment Market Share by Type: 2020 VS 2027
Figure 2. Estetrol Features
Figure 3. Fezolinetant Features
Figure 4. FP-101 Features
Figure 5. HBN-2 Features
Figure 6. Others Features
Figure 7. Global Vasomotor Symptoms of Menopause Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Homecare Case Studies
Figure 10. Clinic Case Studies
Figure 11. Vasomotor Symptoms of Menopause Treatment Report Years Considered
Figure 12. Global Vasomotor Symptoms of Menopause Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Vasomotor Symptoms of Menopause Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Vasomotor Symptoms of Menopause Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Vasomotor Symptoms of Menopause Treatment Market Share by Regions (2022-2027)
Figure 16. Global Vasomotor Symptoms of Menopause Treatment Market Share by Players in 2020
Figure 17. Global Top Vasomotor Symptoms of Menopause Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vasomotor Symptoms of Menopause Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Vasomotor Symptoms of Menopause Treatment Revenue in 2020
Figure 19. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Vasomotor Symptoms of Menopause Treatment Market Share by Type (2016-2027)
Figure 23. North America Vasomotor Symptoms of Menopause Treatment Market Share by Application (2016-2027)
Figure 24. North America Vasomotor Symptoms of Menopause Treatment Market Share by Country (2016-2027)
Figure 25. United States Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Vasomotor Symptoms of Menopause Treatment Market Share by Type (2016-2027)
Figure 29. Europe Vasomotor Symptoms of Menopause Treatment Market Share by Application (2016-2027)
Figure 30. Europe Vasomotor Symptoms of Menopause Treatment Market Share by Country (2016-2027)
Figure 31. Germany Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Share by Region (2016-2027)
Figure 41. China Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Vasomotor Symptoms of Menopause Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Vasomotor Symptoms of Menopause Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Vasomotor Symptoms of Menopause Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amgen Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 61. EndoCeutics, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 62. Euroscreen S.A. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 63. MenoGeniX, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 64. Mithra Pharmaceuticals S.A. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 65. Pherin Pharmaceuticals, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 66. Pivot Pharmaceuticals Inc Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 67. Radius Health, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 68. TherapeuticsMD, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.